Balló H - Search Results

1

Immune complexes are potent inhibitors of interleukin-12 secretion by human monocytes.

Berger S, Chandra R, Balló H, Hildenbrand R, Stutte HJ. Berger S, et al. Among authors: ballo h. Eur J Immunol. 1997 Nov;27(11):2994-3000. doi: 10.1002/eji.1830271136. Eur J Immunol. 1997. PMID: 9394829

2

[Immune complexes induce the secretion of Th2 cytokines in human monocytes].

Berger S, Balló H, Stutte HJ. Berger S, et al. Among authors: ballo h. Verh Dtsch Ges Pathol. 1996;80:288-92. Verh Dtsch Ges Pathol. 1996. PMID: 9065029 German.

3

Immune complex-induced interleukin-6, interleukin-10 and prostaglandin secretion by human monocytes: a network of pro- and anti-inflammatory cytokines dependent on the antigen:antibody ratio.

Berger S, Balló H, Stutte HJ. Berger S, et al. Among authors: ballo h. Eur J Immunol. 1996 Jun;26(6):1297-301. doi: 10.1002/eji.1830260618. Eur J Immunol. 1996. PMID: 8647208

4

Distinct antigen-induced cytokine pattern upon stimulation with antibody-complexed antigen consistent with a Th1-->Th2-shift.

Berger S, Balló H, Stutte HJ. Berger S, et al. Among authors: ballo h. Res Virol. 1996 Mar-Jun;147(2-3):103-8. doi: 10.1016/0923-2516(96)80223-8. Res Virol. 1996. PMID: 8901428

5

Antitumor activity of anti-epidermal growth factor receptor monoclonal antibodies and cisplatin in ten human head and neck squamous cell carcinoma lines.

Hoffmann T, Hafner D, Ballo H, Haas I, Bier H. Hoffmann T, et al. Among authors: ballo h. Anticancer Res. 1997 Nov-Dec;17(6D):4419-25. Anticancer Res. 1997. PMID: 9494544

6

Is there a role for the Fas-/Fas-Ligand pathway in chemoresistance of human squamous cell carcinomas of the head and neck (SCCHN)?

Sproll KC, Balló H, Hoffmann TK, Scheckenbach K, Koldovsky U, Balz V, Hafner D, Ramp U, Bier H. Sproll KC, et al. Among authors: ballo h. Oral Oncol. 2009 Jan;45(1):69-84. doi: 10.1016/j.oraloncology.2008.04.003. Epub 2008 Jul 11. Oral Oncol. 2009. PMID: 18620901

7

Antitumor activity of protein kinase C inhibitors and cisplatin in human head and neck squamous cell carcinoma lines.

Hoffmann TK, Leenen K, Hafner D, Balz V, Gerharz CD, Grund A, Balló H, Hauser U, Bier H. Hoffmann TK, et al. Among authors: ballo h. Anticancer Drugs. 2002 Jan;13(1):93-100. doi: 10.1097/00001813-200201000-00011. Anticancer Drugs. 2002. PMID: 11914646

8

Argon plasma coagulation (APC) in palliative surgery of head and neck malignancies.

Hauser U, Hoffmann TK, Balló H, Bier H. Hauser U, et al. Among authors: ballo h. Laryngoscope. 2002 Jul;112(7 Pt 1):1275-80. doi: 10.1097/00005537-200207000-00025. Laryngoscope. 2002. PMID: 12169913

9

Serum level and tissue expression of c-erbB-1 and c-erbB-2 proto-oncogene products in patients with squamous cell carcinoma of the head and neck.

Hoffmann TK, Balló H, Braunstein S, Van Lierop A, Wagenmann M, Bier H. Hoffmann TK, et al. Among authors: ballo h. Oral Oncol. 2001 Jan;37(1):50-6. doi: 10.1016/s1368-8375(00)00056-7. Oral Oncol. 2001. PMID: 11120483

10

Establishment and characterization of four cell lines derived from human head and neck squamous cell carcinomas for an autologous tumor-fibroblast in vitro model.

Balló H, Koldovsky P, Hoffmann T, Balz V, Hildebrandt B, Gerharz CD, Bier H. Balló H, et al. Anticancer Res. 1999 Sep-Oct;19(5B):3827-36. Anticancer Res. 1999. PMID: 10628319

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results